ArticleHaematologica2010

Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.

Doris Steinemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.